Beyond SSRIs: Analyzing the Pipeline of Novel Mechanisms and Rapid-Acting Therapies Reshaping the Anxiety and Depression Treatment Market
The Anxiety Disorders and Depression Treatment Market is at a pivotal point, moving past the dominance of selective serotonin reuptake inhibitors (SSRIs) and other monoamine-targeting drugs that have formed the backbone of pharmacotherapy for decades. The current market is being reshaped by intense research and development focused on novel mechanisms of action, driven by the need for faster...
0 Commentarios 0 Acciones 520 Views 0 Vista previa